ZIVO Bioscience Inc. (ZIVOW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

ZIVO Bioscience Inc.

NASDAQ: ZIVOW · Real-Time Price · USD
0.55
0.14 (34.15%)
At close: Aug 29, 2025, 11:15 AM
0.55
0.00%
Pre-market: Sep 10, 2025, 11:49 AM EDT

ZIVO Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
157.22K 27.65K n/a n/a
Cost of Revenue
108.27K 16.04K n/a n/a
Gross Profit
48.95K 11.61K n/a n/a
Operating Income
-13.36M -7.26M -8.73M -9.05M
Interest Income
n/a n/a 13.32K 233.28K
Pretax Income
-13.38M -7.78M -8.75M -9.16M
Net Income
-13.38M -7.78M -8.75M -9.4M
Selling & General & Admin
10.28M 5.9M 6.49M 6.93M
Research & Development
3.13M 1.38M 2.24M 2.12M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
13.41M 7.27M 8.73M 9.05M
Interest Expense
22.94K 514.17K 13.32K 233.28K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
13.52M 7.29M 8.73M 9.05M
Income Tax Expense
n/a n/a -4 233.28K
Shares Outstanding (Basic)
3.41M 1.69M 1.57M 1.27M
Shares Outstanding (Diluted)
3.41M 1.69M 1.57M 1.27M
EPS (Basic)
-3.92 -4.6 -5.58 -7.4
EPS (Diluted)
-3.92 -4.6 -5.57 -7.39
EBITDA
-13.36M -7.26M -8.73M -9.05M
EBIT
-13.36M -7.26M -8.73M -8.52M
Depreciation & Amortization
n/a n/a 4.00 -407.49K